1-8 of 8
Fernando Bril
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Advanced Liver Fibrosis Is Common in Patients With Type 2 Diabetes Followed in the Outpatient Setting: The Need for Systematic Screening

Romina Lomonaco, Eddison Godinez Leiva, Fernando Bril, Sulav Shrestha, Lydia Mansour, Jeff Budd, Jessica Portillo Romero, Siegfried Schmidt, Ku-Lang Chang, George Samraj, John Malaty, Katherine Huber, Pierre Bedossa, Srilaxmi Kalavalapalli, Jonathan Marte, Diana Barb, Danielle Poulton, Nada Fanous, Kenneth Cusi
Journal: Diabetes Care
Diabetes Care 2021;44(2):399–406
https://doi.org/10.2337/dc20-1997
Published: 13 January 2021
View article titled, Advanced Liver Fibrosis Is Common in Patients With Type 2 Diabetes Followed in the Outpatient Setting: The Need for Systematic Screening
Open the PDF for Advanced Liver Fibrosis Is Common in Patients With Type 2 Diabetes Followed in the Outpatient Setting: The Need for Systematic Screening in another window
Journal Articles

Performance of Plasma Biomarkers and Diagnostic Panels for Nonalcoholic Steatohepatitis and Advanced Fibrosis in Patients With Type 2 Diabetes

Fernando Bril, Michael J. McPhaul, Michael P. Caulfield, Virginia C. Clark, Consuelo Soldevilla-Pico, Roberto J. Firpi-Morell, Jinping Lai, Dov Shiffman, Charles M. Rowland, Kenneth Cusi
Journal: Diabetes Care
Diabetes Care 2020;43(2):290–297
https://doi.org/10.2337/dc19-1071
Published: 11 October 2019
View article titled, Performance of Plasma Biomarkers and Diagnostic Panels for Nonalcoholic Steatohepatitis and Advanced Fibrosis in Patients With Type 2 Diabetes
Open the PDF for Performance of Plasma Biomarkers and Diagnostic Panels for Nonalcoholic Steatohepatitis and Advanced Fibrosis in Patients With Type 2 Diabetes in another window
Includes: Supplementary data
Journal Articles

Role of Vitamin E for Nonalcoholic Steatohepatitis in Patients With Type 2 Diabetes: A Randomized Controlled Trial

Fernando Bril, Diane M. Biernacki, Srilaxmi Kalavalapalli, Romina Lomonaco, Sreevidya K. Subbarayan, Jinping Lai, Fermin Tio, Amitabh Suman, Beverly K. Orsak, Joan Hecht, Kenneth Cusi
Journal: Diabetes Care
Diabetes Care 2019;42(8):1481–1488
https://doi.org/10.2337/dc19-0167
Published: 21 May 2019
View article titled, Role of Vitamin E for Nonalcoholic Steatohepatitis in Patients With Type 2 Diabetes: A Randomized Controlled Trial
Open the PDF for Role of Vitamin E for Nonalcoholic Steatohepatitis in Patients With Type 2 Diabetes: A Randomized Controlled Trial in another window
Includes: Supplementary data
Journal Articles

Use of Plasma Fragments of Propeptides of Type III, V, and VI Procollagen for the Detection of Liver Fibrosis in Type 2 Diabetes

Fernando Bril, Diana Julie Leeming, Morten Asser Karsdal, Srilaxmi Kalavalapalli, Diana Barb, Jinping Lai, Matthew Rabe, Kenneth Cusi
Journal: Diabetes Care
Diabetes Care 2019;42(7):1348–1351
https://doi.org/10.2337/dc18-2578
Published: 21 May 2019
View article titled, Use of Plasma Fragments of Propeptides of Type III, V, and VI Procollagen for the Detection of Liver Fibrosis in Type 2 Diabetes
Open the PDF for Use of Plasma Fragments of Propeptides of Type III, V, and VI Procollagen for the Detection of Liver Fibrosis in Type 2 Diabetes in another window
Includes: Supplementary data
Journal Articles

Response to Comment on Bril et al. Clinical and Histologic Characterization of Nonalcoholic Steatohepatitis in African American Patients. Diabetes Care 2018;41:187–192

Fernando Bril, Kenneth Cusi
Journal: Diabetes Care
Diabetes Care 2018;41(9):e137–e138
https://doi.org/10.2337/dci18-0026
Published: 13 August 2018
View article titled, Response to Comment on Bril et al. Clinical and Histologic Characterization of Nonalcoholic Steatohepatitis in African American Patients. Diabetes Care 2018;41:187–192
Open the PDF for Response to Comment on Bril et al. Clinical and Histologic Characterization of Nonalcoholic Steatohepatitis in African American Patients. Diabetes Care 2018;41:187–192 in another window
Journal Articles

Clinical and Histologic Characterization of Nonalcoholic Steatohepatitis in African American Patients

Fernando Bril, Paola Portillo-Sanchez, I-Chia Liu, Srilaxmi Kalavalapalli, Kristin Dayton, Kenneth Cusi
Journal: Diabetes Care
Diabetes Care 2018;41(1):187–192
https://doi.org/10.2337/dc17-1349
Published: 13 November 2017
View article titled, Clinical and Histologic Characterization of Nonalcoholic Steatohepatitis in African American Patients
Open the PDF for Clinical and Histologic Characterization of Nonalcoholic Steatohepatitis in African American Patients in another window
Includes: Supplementary data
Journal Articles

Management of Nonalcoholic Fatty Liver Disease in Patients With Type 2 Diabetes: A Call to Action

Fernando Bril, Kenneth Cusi
Journal: Diabetes Care
Diabetes Care 2017;40(3):419–430
https://doi.org/10.2337/dc16-1787
Published: 13 February 2017
View article titled, Management of Nonalcoholic Fatty Liver Disease in Patients With Type 2 Diabetes: A Call to Action
Open the PDF for Management of Nonalcoholic Fatty Liver Disease in Patients With Type 2 Diabetes: A Call to Action in another window
Includes: Supplementary data
Journal Articles

Metabolic Impact of Nonalcoholic Steatohepatitis in Obese Patients With Type 2 Diabetes

Romina Lomonaco, Fernando Bril, Paola Portillo-Sanchez, Carolina Ortiz-Lopez, Beverly Orsak, Diane Biernacki, Margaret Lo, Amitabh Suman, Michelle H. Weber, Kenneth Cusi
Journal: Diabetes Care
Diabetes Care 2016;39(4):632–638
https://doi.org/10.2337/dc15-1876
Published: 09 February 2016
View article titled, Metabolic Impact of Nonalcoholic Steatohepatitis in Obese Patients With Type 2 Diabetes
Open the PDF for Metabolic Impact of Nonalcoholic Steatohepatitis in Obese Patients With Type 2 Diabetes in another window
Includes: Supplementary data